Log in

Relevant bibliographies by topics / AIDS dementia complex - Pathogenesis / Journal articles

Journal articles on the topic 'AIDS dementia complex - Pathogenesis'

To see the other types of publications on this topic, follow the link: AIDS dementia complex - Pathogenesis.

Author: Grafiati

Published: 4 June 2021

Last updated: 6 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'AIDS dementia complex - Pathogenesis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Dal Canto, M. C. "AIDS-Dementia-Complex: pathology, pathogenesis and future directions." Italian Journal of Neurological Sciences 10, no. 3 (June 1989): 277–87. http://dx.doi.org/10.1007/bf02333773.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Berman, N. E. J., J. K. Johnson, L. Raymond, E. B. Stephens, S. Joag, and O. Narayan. "Pathogenesis of the aids dementia complex in the SIV model." European Neuropsychopharmacology 6 (June 1996): 22. http://dx.doi.org/10.1016/0924-977x(96)87400-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

McCaddon, A., B. Regland, and C. F. Fear. "Trypsin inhibition: A potential cause of cobalamin deficiency common to the pathogenesis of Alzheimer-type dementia and AIDS dementia complex?" Medical Hypotheses 45, no. 2 (August 1995): 200–204. http://dx.doi.org/10.1016/0306-9877(95)90069-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Krivine, Anne, Gilles Force, Jerome Servan, Anne-Elisabeth Cabée, Flore Rozenberg, Lucia Dighiero, Françoise Marguet, and Pierre Lebon. "Measuring HIV-1 RNA and interferon-α in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex." Journal of Neurovirology 5, no. 5 (January 1999): 500–506. http://dx.doi.org/10.3109/13550289909045379.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Cunningham, A. L., H. Naif, N. Saksena, G. Lynch, J. Chang, S. Li, R. Jozwiak, et al. "HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype." Journal of Leukocyte Biology 62, no. 1 (July 1997): 117–25. http://dx.doi.org/10.1002/jlb.62.1.117.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Perrella, O., M. Guerriero, E. Izzo, M. Soscia, and P. B. Carrieri. "Interleukin-6 and granulocyte macrophage-csf in the cerebrospinal fluid from hiv infected subjects with involvement of the central nervous system." Arquivos de Neuro-Psiquiatria 50, no. 2 (June 1992): 180–82. http://dx.doi.org/10.1590/s0004-282x1992000200008.

Full text

Abstract:

We detected the cytokines interleukin-6 (IL-6) and granulocyte macrophage-CSF (GM-CSF) by ELISA in the CSF and serum of 30 HIV-infected patients classified as AIDS dementia complex (ADC), and 20 subjects with other neurological diseases (OND). We have found a high incidence of detectable IL-6 and GM-CSF in the CSF of ADC patients compared with OND patients. No statistical differences were observed between both groups for serum IL-6 and GM-CSF levels. These results suggest an intrathecal synthesis of these cytokines and a possible involvement in the pathogenesis of ADC.

APA, Harvard, Vancouver, ISO, and other styles

7

Price, Richard W. "The AIDS dementia complex as a model for other neurodegenerative diseases: a pathogenetic conceit." Journal of the Neurological Sciences 127, no. 1 (December 1994): 6–7. http://dx.doi.org/10.1016/0022-510x(94)90120-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

A.L. Sidelkovsky, P.A. Fedorov, V.V. Marusichenko, and M.R. Ignatischev. "Damage to the nervous system associated with HIV infection (a clinical case)." INTERNATIONAL NEUROLOGICAL JOURNAL 16, no. 8 (March 10, 2021): 53–56. http://dx.doi.org/10.22141/2224-0713.16.8.2020.221963.

Full text

Abstract:

In Eastern Europe, at least 130 thousand new cases of HIV infection have been registered, which undoubtedly reflects the urgency of this medical problem. In our country, the average rate of human immunodeficiency infection is 58 cases per 100 thousand people. It is known that the disease is caused by an RNA-containing human immunodeficiency virus. Two types of it have been studied — HIV-1 and HIV-2, which have many subtypes. An important clinical feature of this virus is its tropism to cells of the human nervous and immune systems. The main risk group for the disease is injecting drug users, blood recipients, and people with low social responsibility. The impairment of the nervous system in AIDS is represented by the AIDS-dementia complex, acute aseptic meningitis, HIV-associated myelopathy, pathology of the peripheral nervous system, as well as the influence of opportunistic infections and neoplasms. This article presents a clinical case of lesions of the nervous system associated with HIV infection and also considers the etiology, pathogenesis, features of the course, diagnosis, and treatment of patients with neuro-AIDS.

APA, Harvard, Vancouver, ISO, and other styles

9

Lim, Chai K., Bruce J. Brew, Gayathri Sundaram, and Gilles J. Guillemin. "Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression." International Journal of Tryptophan Research 3 (January 2010): IJTR.S4294. http://dx.doi.org/10.4137/ijtr.s4294.

Full text

Abstract:

The kynurenine pathway (KP) is a major degradative pathway of tryptophan ultimately leading to the production of nicotinamide adenine dinucleotide (NAD+) and is also one of the major regulatory mechanisms of the immune response. The KP is known to be involved in several neuroinflammatory disorders including Alzheimer's disease, amyotrophic lateral sclerosis, AIDS dementia complex, Parkinson's disease, schizophrenia, Huntington's disease and brain tumours. However, the KP remains a relatively new topic for the field of multiple sclerosis (MS). Over the last 2–3 years, some evidence has progressively emerged suggesting that the KP is likely to be involved in the pathogenesis of autoimmune diseases especially MS. Some KP modulators are already in clinical trials for other inflammatory diseases and would potentially provide a new and important therapeutic strategy for MS patients. This review summarizes the known relationships between the KP and MS.

APA, Harvard, Vancouver, ISO, and other styles

10

Talley, A. K., S. Dewhurst, S. W. Perry, S. C. Dollard, S. Gummuluru, S. M. Fine, D. New, L. G. Epstein, H. E. Gendelman, and H. A. Gelbard. "Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA." Molecular and Cellular Biology 15, no. 5 (May 1995): 2359–66. http://dx.doi.org/10.1128/mcb.15.5.2359.

Full text

Abstract:

Tumor necrosis factor alpha (TNF-alpha) is a candidate human immunodeficiency virus type 1-induced neurotoxin that contributes to the pathogenesis of AIDS dementia complex. We report here on the effects of exogenous TNF-alpha on SK-N-MC human neuroblastoma cells differentiated to a neuronal phenotype with retinoic acid, TNF-alpha caused a dose-dependent loss of viability and a corresponding increase in apoptosis in differentiated SK-N-MC cells but not in undifferentiated cultures. Importantly, intracellular signalling via TNF receptors, as measured by activation of the transcription factor NF-kappa B, was unaltered by retinoic acid treatment. Finally, overexpression of bcl-2 or crmA conferred resistance to apoptosis mediated by TNF-alpha, as did the addition of the antioxidant N-acetylcysteine. These results suggest that TNF-alpha induces apoptosis in neuronal cells by a pathway that involves formation of reactive oxygen intermediates and which can be blocked by specific genetic interventions.

APA, Harvard, Vancouver, ISO, and other styles

11

Portegies, Peter, and Nathalie R. Rosenberg. "AIDS Dementia Complex." CNS Drugs 9, no. 1 (1998): 31–40. http://dx.doi.org/10.2165/00023210-199809010-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

DeArmond, S. J. "Aids Dementia Complex." Microscopy and Microanalysis 5, S2 (August 1999): 1090–91. http://dx.doi.org/10.1017/s1431927600018778.

Full text

Abstract:

The World Health Organization estimates by the year 2000 that the cumulative total of HIV-1 infected adults and children will be about 30 million worldwide. Disease of the central nervous system (CNS) in association with AIDS is common. 20-30% of AIDS patients will develop varying degrees of cognitive and motor deficits designated the “AIDS dementia Complex (ADC)” or “HIV-1-associated cognitive/motor deficit”. Progression of symptoms is usually slow and irregular. In the end-stage, the patient is severely impaired with mutism, incontinence and prominent motor impairment. Neuroradiologic studies show generalized cortical atrophy and diffuse white matter changes. HIV can be cultured from the CSF. Neurologic involvement in pediatric AIDS is very common with CNS complications usually occurring within the first two postnatal years. Given the severeness of the dementia and motor dysfunction in ADC, one is struck by the paucity of neuropathological features. Hematoxylin and eosin stained sections reveal only three neuropathological features. First, there are small numbers of microglial nodules scattered in the white matter and sometimes in grey matter (Fig. 1). However, microglial nodules occur in virtually all viral infections of the CNS, including CMV micronodular encephalitis in AIDS patients.

APA, Harvard, Vancouver, ISO, and other styles

13

Katz, Anne. "AIDS Dementia Complex." Journal of Palliative Care 10, no. 1 (March 1994): 46–50. http://dx.doi.org/10.1177/082585979401000112.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Brew, Bruce James. "AIDS DEMENTIA COMPLEX." Neurologic Clinics 17, no. 4 (November 1999): 861–81. http://dx.doi.org/10.1016/s0733-8619(05)70170-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Prockop, Leon D. "AIDS dementia complex." Journal of Legal Medicine 9, no. 4 (December 1988): 509–17. http://dx.doi.org/10.1080/01947648809513542.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Wilson, Susan E. "AIDS Dementia Complex." AIDS Patient Care 3, no. 5 (October 1989): 20–22. http://dx.doi.org/10.1089/apc.1989.3.20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Weisberg, Leon A., and Web Ross. "AIDS dementia complex." Postgraduate Medicine 86, no. 1 (July 1989): 213–20. http://dx.doi.org/10.1080/00325481.1989.11704337.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Vinters, Harry V. "The AIDS dementia complex." Annals of Neurology 21, no. 6 (June 1987): 612. http://dx.doi.org/10.1002/ana.410210618.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Price, R. W., and B. J. Brew. "The AIDS Dementia Complex." Journal of Infectious Diseases 158, no. 5 (November 1, 1988): 1079–83. http://dx.doi.org/10.1093/infdis/158.5.1079.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Wu, Yun-Cheng, Yong-Bo Zhao, Meng-Guang Tang, Sandy Xinyu Zhang-Nunes, and Justin C. McArthur. "AIDS dementia complex in China." Journal of Clinical Neuroscience 14, no. 1 (January 2007): 8–11. http://dx.doi.org/10.1016/j.jocn.2005.07.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Portegies, Peter, RoelienH Enting, MennoD de Jong, SvenA Danner, Peter Reiss, Jaap Goudsmit, and JoepMA Lange. "AIDS dementia complex and didanosine." Lancet 344, no. 8924 (September 1994): 759. http://dx.doi.org/10.1016/s0140-6736(94)92252-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Perrella, Oreste, Alessandro Perrella, Marco Perrella, Costanza Sbreglia, and Gugliemo Borgia. "Cytokines and AIDS dementia complex." AIDS 17, no. 1 (January 2003): 134–36. http://dx.doi.org/10.1097/00002030-200301030-00022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Morriss, R., and A. House. "Zidovudine in AIDS dementia complex." BMJ 299, no. 6709 (November 11, 1989): 1218. http://dx.doi.org/10.1136/bmj.299.6709.1218-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Baert, A. E. "Neuropathology of Aids and the Aids-dementia complex." Clinical Neurology and Neurosurgery 91, no. 4 (January 1989): 370. http://dx.doi.org/10.1016/0303-8467(89)90043-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Buhrich, Neil. "HIV, Psychosis and AIDS Dementia Complex." Australasian Psychiatry 3, no. 4 (August 1995): 238–39. http://dx.doi.org/10.3109/10398569509080418.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Buckingham, Stephan L., and Wilfred G. Van Gorp. "AIDS-Dementia Complex: Implications for Practice." Social Casework 69, no. 6 (June 1988): 371–75. http://dx.doi.org/10.1177/104438948806900608.

Full text

Abstract:

AIDS and the dementia associated with it have created new challenges for social workers. The authors identify unique issues around the AIDS-dementia complex. Implications for social work practice are discussed, and recommendations for assisting the growing population with this complex are made.

APA, Harvard, Vancouver, ISO, and other styles

27

Navia, Bradford A., Eun-Sook Cho, Carol K. Petito, and Richard W. Price. "The AIDS dementia complex: II. Neuropathology." Annals of Neurology 19, no. 6 (June 1986): 525–35. http://dx.doi.org/10.1002/ana.410190603.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Maher, John, Rshujeel Choudhri, William Halliday, Christopher Power, and Avindra Nath. "AIDS dementia complex with generalized myoclonus." Movement Disorders 12, no. 4 (July 1997): 593–97. http://dx.doi.org/10.1002/mds.870120418.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

SCHARNHORST, SUSANNE. "AIDS Dementia Complex in the Elderly." Nurse Practitioner 17, no. 8 (August 1992): 37,41–43. http://dx.doi.org/10.1097/00006205-199208000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Patton, Holly K., Etty Benveniste, and Dale J. Benos. "Astrocytes and the AIDS Dementia Complex." Journal of Neuro-AIDS 1, no. 1 (October 12, 1995): 111–31. http://dx.doi.org/10.1300/j128v01n01_06.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Meehan, Rebecca A., and Jennifer A. Brush. "An overview of AIDS dementia complex." American Journal of Alzheimer's Disease & Other Dementiasr 16, no. 4 (July 2001): 225–29. http://dx.doi.org/10.1177/153331750101600411.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Katz, Anne. "Delayed Diagnosis of AIDS Dementia Complex." AIDS Patient Care 8, no. 4 (August 1994): 183–84. http://dx.doi.org/10.1089/apc.1994.8.183.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Verma, R. C., L. R. Bennett, M. P. Can, G. Mathiesen, F. Kiouraehr, W. Riege, C. Wasterlain, and F. D. Jones. "NONINVASIVE EVALUATION OF AIDS DEMENTIA COMPLEX." Clinical Nuclear Medicine 14, Supplement (September 1989): P12. http://dx.doi.org/10.1097/00003072-198909001-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Price, Richard W. "The AIDS dementia complex: Current status." Journal of Neuroimmunology 16, no. 1 (September 1987): 4. http://dx.doi.org/10.1016/0165-5728(87)90136-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Ho, David D. "The Acquired Immunodeficiency Syndrome (AIDS) Dementia Complex." Annals of Internal Medicine 111, no. 5 (September 1, 1989): 400. http://dx.doi.org/10.7326/0003-4819-111-5-400.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Price, Richard W., John Sidtis, and Marc Rosenblum. "The aids dementia complex: Some current questions." Annals of Neurology 23, S1 (1988): S27—S33. http://dx.doi.org/10.1002/ana.410230711.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Navia, Bradford A., Barry D. Jordan, and Richard W. Price. "The AIDS dementia complex: I. Clinical features." Annals of Neurology 19, no. 6 (June 1986): 517–24. http://dx.doi.org/10.1002/ana.410190602.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

von Einsiedel, R. Grafin, E. Minami, D. L. Secor, S. Pang, I. S. Y. Chen, and H. V. Vinters. "STRUCTURAL COMPONENTS OF THE AIDS DEMENTIA COMPLEX." Journal of Neuropathology and Experimental Neurology 49, no. 3 (May 1990): 351. http://dx.doi.org/10.1097/00005072-199005000-00277.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Portegies, Peter, Roelien H. Enting, Jan de Gans, Paul R. Algra, Mayke M. A. Derix, Joep M. A. Lange, and Jaap Goudsmit. "Presentation and course of AIDS dementia complex." AIDS 7, no. 5 (May 1993): 669–76. http://dx.doi.org/10.1097/00002030-199305000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Tross, Susan, Richard W. Price, Bradford Navia, Howard T. Thaler, Jonathan Gold, Dan Alan Hirsch, and John J. Sidtis. "Neuropsychological characterization of the AIDS dementia complex." AIDS 2, no. 2 (April 1988): 81–88. http://dx.doi.org/10.1097/00002030-198804000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Chiesi, A., S. Vella, L. G. Dally, C. Pedersen, S. Danner, A. M. Johnson, S. Schwander, F. D. Goebel, M. Glauser, and F. Antunes. "Epidemiology of AIDS Dementia Complex in Europe." Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11, no. 1 (January 1996): 39–44. http://dx.doi.org/10.1097/00042560-199601010-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Schutzer, Steven E. "234 Autoimmune role in AIDS dementia complex." Journal of Allergy and Clinical Immunology 81, no. 1 (January 1988): 227. http://dx.doi.org/10.1016/0091-6749(88)90469-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Fiala, Milan, Elyse J. Singer, Michael C. Graves, Wallace W. Tourtellotte, John A. Stewart, Charles A. Schable, Roy H. Rhodes, and Harry V. Vinters. "AIDS dementia complex complicated by cytomegalovirus encephalopathy." Journal of Neurology 240, no. 4 (1993): 223–31. http://dx.doi.org/10.1007/bf00818709.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Estep, G. "The aids dementia complex: I. Clinical features." Journal of Emergency Medicine 5, no. 2 (January 1987): 166. http://dx.doi.org/10.1016/0736-4679(87)90098-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Jubelt, Burk. "Abacavir for treatment of AIDS dementia complex." Current Neurology and Neuroscience Reports 1, no. 6 (November 2001): 516–17. http://dx.doi.org/10.1007/s11910-001-0055-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Kim, Dennis M., Robert Tien, Christopher Byrum, and K. Ranga Rama Krishnan. "Imaging in acquired immune deficiency syndrome dementia complex (AIDS dementia complex): A review." Progress in Neuro-Psychopharmacology and Biological Psychiatry 20, no. 3 (April 1996): 349–70. http://dx.doi.org/10.1016/0278-5846(96)00002-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Power, Christopher, and Richard T. Johnson. "HIV-1 Associated Dementia: Clinical Features and Pathogenesis." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 22, no. 2 (May 1995): 92–100. http://dx.doi.org/10.1017/s0317167100040154.

Full text

Abstract:

AbstractHIV-1 infection is characterized by multiple neurological syndromes occuring at all stages of infection. HIV-1-associated dementia, however, is the most devastating CNS consequence of AIDS because of its poor prognosis and functional impairment. A clinical triad of progressive cognitive decline, motor dysfunction, and behavioural abnormalities typifies this subcortical dementia which eventually affects 15 to 20% of AIDS patients. Neuroimaging, CSF studies and neuropsychological testing are frequently required in diagnosing HIV-associated dementia, to exclude other conditions including psychiatric illnesses, opportunistic diseases and systemic disorders. The pathogenesis of HIV dementia is uncertain and there is evidence that multiple mechanisms of neurological injury occur. These mechanisms include: the role of neurovirulent strains of HIV; the potential neurotoxicity of HIV gp120, nitric oxide and quinolinic acid; immunologically mediated CNS injury through the action of cytokines and arachidonic acid metabolites; and altered blood-brain barrier permeability. A collective approach involving clinical studies,in vitroassays and animal models will provide greater insight into the pathogenesis and the rational development of therapy for HIV dementia.

APA, Harvard, Vancouver, ISO, and other styles

48

&NA;. "Zidovudine may delay onset of AIDS dementia complex." Inpharma Weekly &NA;, no. 1022 (February 1996): 16. http://dx.doi.org/10.2165/00128413-199610220-00031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Brew, Bruce J. "HAART in AIDS dementia complex and palliative care." Progress in Palliative Care 12, no. 4 (August 2004): 171–77. http://dx.doi.org/10.1179/096992604225006370.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Rottenberg, D. A., J. R. Moeller, S. C. Strother, J. J. Sidtis, B. A. Navia, V. Dhawan, J. Z. Ginos, and R. W. Price. "The metabolic pathology of the AIDS dementia complex." Annals of Neurology 22, no. 6 (December 1987): 700–706. http://dx.doi.org/10.1002/ana.410220605.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!